Phosphorus is a treat minerals found in some foods such as Cereal Grains, Pasta, Pumpkin, Squash, and Watermelon Seeds. It plays an important role in proper cell functioning, regulation of calcium, strong bones and teeth, and for making ATP (adenosine triphosphate) and also the phospholipids that form all cell membranes(1a).
Phosphorus and bone health
Phosphorus, which constitutes hydroxyapatite with calcium, is a important component of bone. It is considered that there is no need to worry about the lack of phosphorus in the ordinary dietary habits, because a various of foods contain phosphorus. There is a report of parathyroid hormone and bone resorption markers are increased in case of low calcium/phosphorus intake ratio. In the Dietary reference intakes for Japanese, 2010, shows 3,000 mg/day as a tolerable upper intake level of phosphorus. Some issues such as the intake ratio of calcium to phosphorus and an effect of organic phosphorus and inorganic phosphorus remain to be solved. SOURCE
Tuesday, February 26, 2013
Phosphorus and Cost Containment
Monday, June 25, 2012
A simple vitamin can strengthern your bones
Natural vitamin K2 in the form of natural MK-7 builds bone strength, helps prevent osteoporosis, and protects the heart. Noted vitamin K expert Dr. Cees Vermeer led the European study which found that natural vitamin K2 as MK-7 (MenaQ 7 ®) significantly increases the strength of both the spine and the hip in postmenopausal women. The study also verified earlier findings about the cardiovascular benefits of this nutrient. Specifically, the use of MK-7 results in improvements in vascular elasticity and a decrease in age-related stiffening of the arteries. The dose used in this trial was 180 mcg of natural vitamin K2 as MK-7, which is the level commonly found in Japanese diets. The trial lasted for 3 years, with relevant improvement in the hip neck area being apparent after 2-3 years. This explains why previous, shorter studies have not typically shown MK-7 benefits on bone and cardiovascular health. This is surely welcome news for all of us who are looking to strengthen our bones and protect our hearts naturally. I am pleased with this scientific validation of what I have been reporting for years — MK-7 offers great benefits for both the skeleton and cardiovascular systems.
Tuesday, February 28, 2012
Most Taking Rx for Bone Drugs Quit
There are more natural things you can do to protect bone health. And there are many natural approaches to keeping them strong and healthy.
Walking and weight bearing exercise are great! Learn Tai Chi. Look into Lymphology at IAL.
A healthy diet and the right supplements are great! (Just don't be taking so much calcium. Generally doctors tell you to take about twice what you need and the wrong type - carbonate).
Get hydrated!
Cut down on exposure to EMF and fluoride as well as other environmental toxins (the DEXA test is one of these and so is your cell phone).
Consider drinking nettle tea.
Consider using homeopathic cell salts.
Get tested for and take vitamin D3. (25 OH test)
Watch soy, it can block calcium, and is too often GMO.
Susan Brown PhD has been writing on this subject for years. Check out her book, Better Bones.
By Frederik JoelvingNEW YORK | Mon Feb 27, 2012 5:27pm EST(Reuters Health) - People with the bone-thinning condition osteoporosis often skip the drugs they are prescribed, and telephone counseling does little to change that, according to new research.Selections from over 30 on Natural Health News
Researchers said osteoporosis is involved in more than two million fractures a year in the U.S., racking up medical costs of $19 billion.
In addition to exercise and a healthy diet with enough calcium and vitamin D, as well as measures to prevent falls, medications may reduce the risk of broken bones -- which can take a serious toll on the health of old people.
For people at high risk, bone drugs such as bisphosphonates may cut the yearly fracture risk from five percent to three percent, said Dr. Daniel Solomon of Brigham and Women's Hospital in Boston.
But people often stop taking the medications, added Solomon, also of Harvard Medical School.
"It's the problem with all chronic conditions," he told Reuters Health. "Drugs for asymptomatic chronic conditions are universally poorly adhered to."
Some 10 million Americans currently suffer from bone thinning, according to the National Osteoporosis Foundation. The majority are postmenopausal women.
Bone drugs include Merck's Fosamax, Roche's Boniva, Novartis's Reclast and Warner Chilcott's Actonel.
To see if they could convince people to take their drugs, Solomon and his colleagues divided more than 2,000 men and women with osteoporosis into two groups.
The participants were all on Medicare, the government's health insurance for the elderly, and got their meds for a co-pay of no more than a few dollars.
All of them received fall-prevention lifestyle tips in the mail from the researchers, and one group also had about eight counseling sessions over the phone.
During those sessions, trained counselors tried to identify why people skipped their drugs and to motivate them to get back on the treatment. The intervention ended up costing about $281 per patient, including training of the counselors.
After one year, there was little difference between the two groups.
Those who got counseling filled their prescriptions 49 percent of the time, while the others did so 41 percent of the time, based on claims data. That gap was too small to be reliable, statistically speaking.
The researchers didn't find any differences in how many people broke a bone or reported falls, either.
According to Solomon, people who skipped their medicine often said they had forgotten about it, didn't like the way it made them feel or didn't think they needed it.
Still, Solomon, whose findings appear in the Archives of Internal Medicine, wasn't willing to give up on counseling.
"It would be overstating the data to say that we should use this. What I'm saying is you don't want to throw the baby out with the bathwater," he said. "I think that counseling is something we need to continue to examine."
Researchers have been experimenting with a lot of ways to get people to take their drugs, including beeping pill caps and financial incentives, Solomon added. But the results have often been disappointing.
"At this point there really aren't any proven interventions," he said.
In an editorial, Dr. Seth Berkowitz and Dr. Kirsten Johansen of the University of California, San Francisco, say behavior change is an increasingly important part of medicine as chronic diseases continue rise.
"There is likely no 'magic bullet' in the behavior change arsenal in general or for increasing treatment adherence specifically," they write. "This does not mean, however, that the effects may not be clinically significant."
SOURCE: bit.ly/yMrnv4 Archives of Internal Medicine, February 27, 2012.
Friday, July 30, 2010
Calcium and Bone Health

UPDATE: 4 August - NattoPharma says calcium research highlights vitamin K role
Norwegian vitamin K supplier NattoPharma has backed the role of vitamin K in calcium metabolism following the controversial British Medical Journal meta-analysis linking calcium consumption and increased risk of heart attack.
from 30 July, 2010 - One part of this equation seems to be overlooked and that is the type of calcium supplement and the amount of calcium supplementation.
Too often I find that people do not want to spend money for supplements and look for the most inexpensive product rather than a high quality product that will fare them better in the long run.
Numerous studies have been completed that clearly establish the lack of benefit from mas market supplements made with the lowest grade, and most often least effective ingredients.
Calcium carbonate is just one of these ingredients, and its also the main core found in TUMS.
For many not well apprised of the best ways to utilize supplements, TUMS is one of those often suggested by doctors to help bones. Those same doctors are quick to forget that all this calcium overload add a negative effect to the blood buffering system. You know, the buffering system that keeps your blood pH in normal range.
Often this form of calcium can lead to bone spurs and calcium deposits basically because your body just can't metabolize it effectively. We've got better options for you to consider.
And I guess no one told the same doctors that BonAmi, my favorite commercial scouring powder, is made from the very same form of calcium -carbonate!
Calcium pills 'increase' risk of heart attack
By Emma Wilkinson Health reporter, BBC News
Calcium supplements taken by many older people could be increasing their risk of a heart attack, research shows.The study, in the British Medical Journal, said people who took supplements were 30% more likely to have a heart attack.
Data from 11 trials also suggested the medicines were not very effective at preventing bone fractures.
Almost 3m people in the UK are thought to have osteoporosis and many take calcium pills to prevent fractures.
The study recommends doctors review their use of calcium supplements for managing osteoporosis.
The National Osteoporosis Society said most people should be able to get enough calcium through their diets, rather than reaching for the medicine cabinet.
The researchers said those who had a diet naturally high in calcium were at no increased danger.
'Limited benefit'In all 12,000 people aged over 40 took part in the trials of calcium supplements of 500mg or more a day.
The risk of heart attack was seen across men and women, was independent of age and the type of supplement given.
It is a balance of risks - people should consider the risks involved and how they apply to their own circumstances and discuss the matter with their GP” Dr Alison Avenell Study author
A small increased risk of death was seen in the study but was not statistically significant, the researchers said.
The reason for the increased risk of heart attack is not clear but it is thought the extra calcium circulating in the blood could lead to a hardening of the arteries.
Calcium in the diet is safe and the Food Standards Agency recommends adults have 700mg of calcium a day from milk, cheese and green, leafy vegetables.
Dr Alison Avenell, from the University of Aberdeen which did the research with colleagues in New Zealand and the US, said the evidence suggests calcium supplements only have a limited benefit in preventing fractures, especially when compared to other treatments available.
"It is a balance of risks - people should consider the risks involved and how they apply to their own circumstances and discuss the matter with their GP," she said.
She added the results did not necessarily apply to younger people with conditions for which they take calcium.
Judy O'Sullivan, senior cardiac nurse at the British Heart Foundation, said the results should be interpreted with caution because the trials did not set out to look at the risk of heart attack.
"However, the research should not be completely ignored," she said.
"Any new guidelines on the prevention of fractures in those most vulnerable to them should take this type of analysis into account."
Dr Claire Bowring, of the National Osteoporosis Society, said: "We've always recommended that people should aim to get the calcium they need from their diet to help build stronger bones.
"If you get all of the calcium that you need from your diet and adequate vitamin D from exposure to sunshine, then a supplement will not be necessary."
She said there were still questions to be answered about the treatment of osteoporosis but advised people taking calcium supplements to talk to their GP, especially if they have a heart condition.
Wednesday, May 26, 2010
Bone Health and AntiAcid Drugs
The drugs shutdown acid production in the stomach that impairs protein metabolism because you must have acid to digest protein. Lacking protein interferes with structural health.
Often reflux symptoms are from too little stomach acid rather than too much and yet your mainstream doctor does not evaluate this condition. Any easy test can tell you more using an available supplement.
You may also not have enough enzymatic function and you may eat too fast without thoroughly chewing your food, or eat too many unhealthy foods or smoke.
Anti-acid drugs also impair the P450 detox pathway in your liver, among many of the problems they cause.
Here are a few things to consider already known to Big Pharma: Notice that two of the drugs are fluoride based compounds and all have a benzene component.
The active ingredient in PREVACID Delayed-Release Capsules, PREVACID for Delayed-Release Oral Suspension and PREVACID SoluTab Delayed- Release Orally Disintegrating Tablets is lansoprazole, a substituted benzimidazole, 2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl] methyl] sulfinyl] benzimidazole, a compound that inhibits gastric acid secretion.
Musculoskeletal System - arthralgia, arthritis, bone disorder, joint disorder, leg cramps, musculoskeletal pain, myalgia, myasthenia, ptosis, synovitis
NEXIUM Musculoskeletal: arthralgia, arthritis aggravated, arthropathy, cramps, fibromyalgia syndrome, hernia, polymyalgia rheumatica;
The active ingredient in PROTONIX (pantoprazole sodium) For Delayed-Release Oral Suspension and PROTONIX (pantoprazole sodium) Delayed-Release Tablets is a substituted benzimidazole, sodium 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl] sulfinyl]1H-benzimidazole sesquihydrate, a compound that inhibits gastric acid secretion.
Musculoskeletal Disorders: rhabdomyolysis
PRILOSEC Musculoskeletal: Muscle weakness, myalgia, muscle cramps, joint pain, leg pain
You may wish to check all the other information here at Natural Health News about these drugs using the search box.
We also have listed some natural approaches to resolving acid excess.
Please note that these drugs are not good for babies and young children which is a common practice today. Elders may have more problems with the drugs because of delayed metabolism times. In the May 10 Archives of Internal Medicine it is reported that PPI use was associated with a 42% increase in the risk of recurrent C. difficile infection, with the greatest risk among patients older than 80 and in patients treated with antibiotics that were not targeted to the bacterium.
US FDA says acid reflux drugs carry fracture riskhttp://www.medpagetoday.com/Gastroenterology/GERD/20030
Reuters, Tuesday May 25 2010
* FDA recommends lower dose, shorter duration of use
* Drugs include Nexium, Prilosec, Prevacid, Protonix
* Package insert labels to include fracture-risk warnings
NEW YORK, May 25 (Reuters) - U.S. health regulators have cautioned doctors and patients of an increased risk of fractures of the hip, wrist, and spine from high doses or long-term use of a widely used class of drugs to control the amount of acid in the stomach.
The class of heartburn drugs, called proton pump inhibitors, include prescription brands such as AstraZeneca Plc's top-selling Nexium and the company's Prilosec, an older generic treatment that is also available over the counter at a lower dosage strength.
The U.S. Food and Drug Administration said on Tuesday that studies suggest a possible increased risk of bone fractures with the use of proton pump inhibitors for one year or longer, or at high doses.
Package insert labels for the drugs will be changed to describe the possible increased fracture risks, the FDA said.
"Because these products are used by a great number of people, it's important for the public to be aware of this possible increased risk," Joyce Korvick, deputy director for safety in the FDA's Division of Gastroenterology Products, said in an agency statement.
"When prescribing proton pump inhibitors, health care professionals should consider whether a lower dose or shorter duration of therapy would adequately treat the patient's condition," Korvick said.
Moreover, the FDA said doctors and patients should weigh whether known benefits of the drugs outweigh potential risks.
Other proton pump inhibitors used to treat heartburn, known formally as gastroesophageal reflux disease (GERD), include generically available Protonix, Johnson & Johnson's prescription Aciphex brand and Novartis AG's over-the-counter Prevacid.
The FDA recommended that consumers report any side effects or other product problems to its MedWatch Adverse Event Reporting program at http://www.fda.gov/MedWatch or by calling 800-332-1088. (Reporting by Ransdell Pierson, Bill Berkrot and Lewis Krauskopf; Editing by Tim Dobbyn)
Monday, May 10, 2010
Exercise 180+ minutes weekly for better bones
Exercise can forestall osteoporosis
ScienceDaily (2010-05-08) -- The stage for osteoporosis is set well before menopause -- but exercise can help rewrite the script, according to researchers. They hypothesize that higher levels of follicle-stimulating hormone decrease bone mineral density by influencing the production of cytokines. ... > read full article
Tuesday, April 20, 2010
Olive Oil Builds Bones
...many of the imported oils failed to meet international and U.S. standards for EVOO. Worse, sensory panelists found that some oils tasted rancid, fusty and musty. Apparently, they had oxydized–or deteriorated, like the above-mentioned 1989 Taurus–and were adulterated with cheaper oil and/or made from poor quality or overripe olives. California-produced oils did better; only 10 percent failed the tests. Some of the best-known brands didn’t qualify as EV: Bertolli, Pompeian, Colovita, Carapelli, Newman’s Own, Mezzetta and Mazola. Even Rachael Ray’s EVOO underperformed. McEvoy Ranch and Caliornia Olive Ranch were the top scorers, but turning in a not too shabby performance was Kirkland Organic, which comes to you courtesy of humble Costco. READ more
Is it true that the less expensive olive oils on the market are inferior to the expensive ones?
Unfortunately, the best quality olive oils are also usually the most expensive. The best quality oil is an extra virgin olive oil made from organically grown olives.
Extra virgin olive oil is made from the first pressing of the olives, contains the lowest level of acidity (the marketplace standard for labeling is less than 1%), the best taste, and the highest level of antioxidant phytonutrients. The next best after extra virgin would be virgin olive oil. While it is also made from the first pressing of the olives, it has less antioxidants, more acidity (up to 2% is allowed), and a taste that is not as rich as extra virgin olive oil.
You'll notice that "pure" olive oil and "light" olive oils are less expensive, but in this case you get what you pay for. These olives oils are by no means as beneficial (let alone flavorful) as extra virgin olive oil.
"Pure" olive oil is actually refined oil that is created through chemical processing. One method of refining olive oil involves the use of a strong sodium hydroxide solution to "wash" the oil; other methods involve steam distillation of the oil. All refinement methods expose the oil to heats of at least 140-160˚F (60-71˚C).
"Light" olive oils are only light in terms of their taste and color; they are not lower in calories or fat. To a certain extent, the richer and deeper shades of color in an olive oil correspond to the concentration of polyphenol phytonutrients in the oil. These polyphenols may be the most heart-supportive nutrients that olives have to offer. Once they are processed out, the oil may become classified as "light," but light and other refined olive oils are nutritionally inferior to extra virgin and virgin olive oils because of this more extensive processing.
The other consideration would be whether or not to buy organic olive oil. There's no question about organic olive oil being your best choice. Although the nutrient richness of the organic oil may not be vastly greater than the nutrient richness of non-organic oil, the presence of toxic residues is likely to be very different. You're very likely to get fewer toxins in the certified organic oil-especially pesticides and fungicides. from WHFOODS.
Olive Oil and Health
UPDATE: 10 May DHA “appears to be a vital constituent of marrow” and enhances bone mineral content
UPDATE:20 April, 2010 MORE HEALTH BENEFITS FROM OLIVE OIL
More on Fats
How olive oil helps 'switch off' genes which lead to conditions including heart disease and arthritisOLIVE OIL BEAUTY BENEFITS - "Truly one of the world's best beauty secrets. It is a natural, hypoallergenic, inexpensive way to moisturize skin. It also provides valuable antioxidants, like Vitamins A and E that can help repair and renew skin that has been damaged from the sun, air pollution, and cigarette smoke. The antioxidants in olive oil help to stimulate health skin cell growth and return skin to a firmer, smoother, and healthier state. Olive oil can be applied to your face and body and helps to keep skin well-moisturized. You can use it as either a night cream or daily moisturizer. Just be sure to apply it to damp skin. Olive oil can also be used as an eye makeup remover, just add a drop or two to a cotton pad it gently removes eye makeup without irritating the delicate skin around the eye area. Over time, it can even help to smooth our under eye wrinkles."
By Jenny Hope, 20th April 2010
Olive oil's health-giving benefits stem from its ability to help 'switch off ' genes that inflame conditions ranging from heart disease to arthritis, claim researchers.
Their discovery shows how the much-praised Mediterranean diet can suppress chronic disorders.
Spanish researchers identified almost 100 genes whose inflammatory activity is dampened by consumption of olive oil, in particular extra virgin olive oil.
Spanish researchers have found a whole new use for olive oil, in particular extra virgin olive oil
Spanish researchers have found a whole new use for olive oil, in particular extra virgin olive oil
Greeks are the biggest consumers of olive oil in the world - eating 20 times more than Britons - while Italians eat ten times as much.
Eating healthy mono-unsaturated fats such as olive oil is known to lower the risk of heart disease.
In Britain, which has one of the highest heart attack rates in the world, much higher levels of animal or saturated fats are eaten.
In the study, 20 patients with metabolic syndrome, which puts them at high risk of developing cardiovascular disease and type 2 diabetes, were asked to eat breakfast foods covered in two types of olive oil.
One was extra virgin olive oil high in phenol compounds - natural antioxidants - while the other type of oil had low levels of phenols.
The volunteers had to avoid drugs, vitamins and other supplements for six weeks before the study started.
Dr Francisco Perez- Jimenez, from the University of Cordoba, said: 'We identified 98 differentially expressed genes when comparing the intake of phenol-rich olive oil with low-phenol olive oil.
'Several of the repressed genes are known to be involved in pro-inflammatory processes, suggesting the diet can switch the activity of immune system cells.'
Olive oil contains omega-6 fats, a form of 'healthy' polyunsaturates known to block the body's response to inflammation in chronic conditions such as heart disease and arthritis.
But the latest study, whose findings are published today in the science journal BMC Genomics, provides a gene-related explanation for some of the anti-inflammatory effect.
Dietitians say a Mediterranean diet also appears to improve vascular function - the flexibility of cells lining the walls of blood vessels, particularly in the heart and circulatory system.
Eating meat increases the risk of bladder cancer, according to research by scientists at the University of Texas.
Xifeng Wu, the 12-year study's lead author, said: 'People who eat a lot of red meat, particularly well-done red meat, seem to have a higher likelihood of bladder cancer.'
More than 10,000 Britons are diagnosed with bladder cancer every year.
ORIGINALLY POSTED 22 Feb, 09
Olive oil has women bone-preserving properties
by S. C.
A study from the Harokopio University of Athens (Greece) determines that adherence to a dietary pattern close to the Mediterranean diet, with high consumption of fish and olive oil and low red meat intake, has a significant impact in women skeletal health.
Results suggest that this eating pattern could have bone-preserving properties throughout adult life.
Diet is one of the modifiable factors for the development and maintenance of bone mass. The nutrients of most obvious relevance to bone health are calcium and phosphorus because they compose roughly 80% to 90% of the mineral content of bone; protein, other minerals and vitamins are also essential in bone preservation.
Traditional analysis has focused on the relation between a specific nutrient (e.g. calcium) and bone health. But, researchers of the Harokopio University of Athens, Greece, carried out a study in two hundred twenty adult Greek women, which is valuable for the understanding of the effect of meals, consisting of several food items, in skeletal mass.
Scientists examined whether adherence to the Mediterranean Diet, rich in plant foods and olive oil, low in meat and dairy products, and with moderate intake of alcohol, or other dietary patterns, have any significant impact on bone mass maintenance in adult Greek women. They determined that adherence to a dietary pattern with some of the features of the Mediterranean diet, i.e., rich in fish and olive oil and low in red meat and products, is positively associated with the indices of bone mass.
Teatro Naturalle, by S. C. 22 February 2009 TN 1 Year 1
Monday, June 15, 2009
Even More Evidence Links Glitazones to Broken Bones
Perhaps this is another issue to be raised in the insurance debacle, cut payments to Big Pharma for dangerous drugs allowed on the market before real effects of the drugs are fully discovered.
See also: http://naturalhealthnews.blogspot.com/2008/12/avandia-increases-bone-risk-for-women.html
----------
15 June
ADA 2009: More Evidence Links Glitazones to Broken Bones
Shelley Wood
June 12, 2009 (New Orleans, Louisiana) - The largest study to date looking at whether the risk of bone fractures is increased in the setting of thiazolidinedione drugs (TZDs) suggests that fracture risk is more than 40% higher in people taking TZDs and that both men and women are vulnerable [1].
The analysis, presented by Dr Merri Pendergrass (Harvard University, Boston, MA) and colleagues during the American Diabetes Association (ADA) 2009 Scientific Sessions, looked at almost 70 000 patients taking either rosiglitazone (Avandia, GlaxoSmithKline) or pioglitazone (Actos, Takeda) and, unlike other studies, found no difference in fracture risk between the two TZDs.
"I think these agents should be avoided in people at high risk for fracture--unless, of course, particular benefits for a particular patient seem high," Pendergrass told heartwire --for example, a patient with high hypoglycemia risk who is not a good candidate for other classes of medications. Of note, Pendergrass continued, diabetes itself increases the risk for fracture. "So a postmenopausal woman with diabetes would have a particularly high risk--especially if she smoked, had a family history of fracture, or other additional fracture risk factors."
Pendergrass and colleagues reviewed the Medco database--more than 13 million people--looking for all patients between the ages of 43 and 63 at study onset with diabetes and a TZD prescription or any diabetic patients within the same age group taking metformin, exenatide (Byetta, Amylin/Lilly), or a sulfonylurea. They then used a linear-regression model to adjust for age, chronic obstructive pulmonary disease (COPD), asthma, osteoporosis, stroke, and prior fracture to compare fracture risks in patients with "glitazone" prescriptions and in patients with no TZD prescription over the study period (January 2006 through June 2008).
They found that fracture rates were higher among all patients taking TZDs, with no difference between those taking pioglitazone vs rosiglitazone. Fracture rate was also higher in both women taking TZDs vs controls and in men taking TZDs vs controls (although the fracture rate was higher in women than men). According to Pendergrass, this is the first study to show an increased fracture rate in men as well as women. Of note, however, an analysis that looked only at recent TZD prescriptions did not find an increased fracture risk in men, suggesting that men may need to be on the drugs for longer than 18 months before developing an increased risk of broken bones.
Both older women and older men (age 50 to 65 at study conclusion) had a significantly increased fracture risk, but in younger subjects (age 43 to 49) only women were at significantly increased risk. Of note, the study could not control for alcohol consumption and smoking, both of which are known risk factors for fractures. Older adults (age 65 and older) could not be included in the analysis, due to a lack of data, the authors note.
Odds Ratios for Fracture Risk Group Odds ratio 95% CI
All patients 1.43 1.35–1.50
All women 1.55 1.44–1.65
All men 1.26 1.16–1.38
New TZD Rx, women* 1.40 1.19–1.64
New TZD Rx, men* 1.09 0.88–1.35
Rosiglitazone vs pioglitazone 1.03 0.96–1.11
*<18 mo
Pendergrass has previously disclosed research grant support from Novo-Nordisk.
References
Aubert RE, Herrera V, Tully L, et al. Thiazolidinedione treatment increases the risk of fracture. American Diabetes Association 2009 Scientific Sessions; June 7, 2009; New Orleans, LA. 601-P. Authors and Disclosures
Shelley Wood is a journalist for theheart.org, part of the WebMD Professional Network. She has been with theheart.org since 2000, and specializes in interventional cardiology. She studied literature at McGill University and the University of Cape Town and received her graduate degree in journalism from the University of British Columbia, specializing in health reporting. She can be reached at SMWood@webmd.net.
Heartwire © 2009 Medscape, LLC
Wednesday, February 18, 2009
Yes, rBGH is a thing of the past, so we are told
Yoplait, the not real yoghurt stuff promoted mainly to women under many sorts of advertising, especially connected to the fraudulent pink lid campaign, may still be hiding health from you.
While everyone is now happy with General Mills for telling us they decided, after a lot of pressure, to stop using rBGH (recombinant or genetically modified - bovine growth hormone containing milk for their Yoplait brand of products.
Of course you need to ask what else they might not be telling you.
Yoplait might not be telling you that aspartame is still in their "light" versions. Aspartame is a known carcinogen and that is exactly why people in Hawaii and New Mexico are now attempting to get the substance banned from their states.
They might also not be telling you that using low fat or non fat milk to manufacture their product will keep you from getting to be able to sue the calcium that you think is in all dairy food and helps give you healthy bones. Yes, ladies, you really do need fat in milk to be able to absorb and utilize the calcium because it is a fat dependent nutrient.
Have they mentioned that the sugar used ion their fruit versions also block the absorption of both calcium and protein?
And what about the high level of phosphorus in their products?
And just why is it so hard these days to get unpasteurized (raw) milk, something previously easy to purchase within the last 20 years?
Be that as it is, a colleague happened to send along this morning from one of his recent articles:
Yogurt is also heavily promoted as a good calcium source. Aside from the fact that a great many people have dairy food sensitivities that make these foods congesting and a causative factor in a wide variety of catarrhal disorders, yogurt can only serve as a source of absorbable calcium if it is prepared from unpasteurized milk and is unsweetened. The uptake of calcium from the small intestine into the blood is inhibited by the presence of sugar.
Plain unadulterated milk made at home into health promoting yoghurt is a longevity secret of the Bulgarians. Here's some information to help you do some thinking about grocery store quality products.
If you'd rather have a healthier brand try Nancy's or Strauss. Better yet make your own.
Saturday, January 24, 2009
Focus on Bone Health Naturally
There are many articles I've posted here at Natural Health News in the past five years. Bone health is not a lineal process as mainstream medicine pundits would have you believe. It isn't even properly evaluated with the bone density testing offered around the country; the ones that allegedly do the testing by using your heel in a machine (DEXA) that emits radiation. Ultrasound isn't completely revealing either.
You might want to know of a test approved in 2000 at the FDA called the Access Ostase blood test. This test determines bone metabolism by measuring the level of a certain enzyme in the blood called bone-specific alkaline phosphatase (BAP). If a particular osteoporosis therapy is not working, physicians may be able to tell within a matter of months.
Information on lab tests for bone health concerns
"Osteoporosis is a degenerative bone disease affecting roughly 25 million Americans, mostly post-menopausal women. Osteoporosis is currently one of the most under-diagnosed and under-treated disorders in medicine. It is estimated that one-third of women over age 50 have osteoporosis. Osteoporosis is characterized by a decrease in normal bone density due to the loss of calcium and collagen. ***A loss of bone density causes bones to become brittle, and in turn, leads to frequent fractures and other serious effects. Osteoporosis accounts for more than 2.3 million fractures per year in the United States and Europe."
***Just remember that as bone density leads to brittle bones and fracture, so do the prescription osteoporosis drugs.
It isn't as simple as taking a very risky drug your doctor tells you you need to take. Bone health, just like all health is a complex process involving numerous factors, and especially many nutrients.
Nutrient Supports Bone Health Over Time
By Rosalie Marion Bliss, January 14, 2009
Findings from a new study suggest that natural pigments found in plants may help protect against bone loss in older men and women. Researchers funded by the Agricultural Research Service (ARS) reported the findings in a paper published online by The American Journal of Clinical Nutrition.
The study was led by epidemiologist Katherine Tucker with the Jean Mayer USDA Human Nutrition Research Center on Aging (HNRCA) at Tufts University in Boston, Mass. Tucker directs the HNRCA's Dietary Assessment and Epidemiology Research Program.
Other studies have consistently shown that fruit and vegetable intake is good for bones. Biological antioxidants in fruits and vegetables, such as carotenoids, protect cells and tissues from damage caused by naturally occurring oxygen free radicals in the body. Such plant nutrients may help protect the skeleton by reducing oxidative stress and thereby inhibiting bone breakdown or resorption.
The researchers examined potential effects on bone mineral density of overall and individual intake of several carotenoid compounds, including alpha-carotene, beta-carotene, beta-cryptoxanthin, lycopene and lutein+zeaxanthin.
For the observational study, the researchers tracked changes in bone mineral density at two areas of the hip and lumbar spine of male and female volunteers, aged 75 years on average, participating in the Framingham Osteoporosis Study. Among these volunteers, 213 men and 390 women were measured at the beginning of the study and four years later.
Over the course of the four years of the study, carotenoids were associated with some level of protection against losses in bone mineral density at the hip in men and at the lumbar spine in women. No significant associations were observed at the other bone sites.
The results suggest there is a protective effect of carotenoids, particularly of lycopene, against bone loss in older adults. The researchers concluded that carotenoids may explain, in part, the previously observed protective effects of fruit and vegetable consumption on bone mineral density.
To look up the levels of individual carotenoids in selected foods, go to "Reports By Single Nutrients," provided by the ARS Nutrient Data Laboratory at:
http://www.ars.usda.gov/Main/docs.htm?docid=15869
ARS is a scientific research agency of the U.S. Department of Agriculture.
The above report is heartening however much of the information in the report was made known well over a decade ago in the work of Susan Brown, PhD., and many researchers before her.
Other information you may not know. Part of this missing link is the bone-damaging impact from many non-osteoporosis drugs. Another is that there are very effective natural approaches to insure and improve bone health that are not based on bone destroying fluoride drugs.
Please contact us for more information.
________________________________________
While Dr. Karsenty's research may lead to a shift in mainstream medicine I would call for a totally different approach.
We do not need another new drug and we certainly do not need the current fluoride and bisphosphonate type drugs that are replete with a plethora of side effects that can cause cancer and fracture.
I'd like to see a totally different approach like the one I developed for clients that is showing positive benefits of healthy new bone growth and strengthening. Or as an option you might find help with an herbal formula proven at Harvard's Dana Farber I have used with others as their choice.
Not only do we need new health care, we need new ideas and new approaches with out fear of going outside the controlling and repressive "standards of care" controls to keep providers in line with Big Insurance and Big Pharma dictates.
And we need to move from the "study" model to the application model.
It Takes Guts To Build Bone, Scientists Discover
ScienceDaily (2008-12-01) -- Bone growth is controlled in the gut through serotonin, the same naturally present chemical used by the brain to influence mood, appetite and sleep, according to a new discovery. Until now, the skeleton was thought to control bone growth and serotonin was known as a neurotransmitter acting in the brain. This insight could transform how osteoporosis is treated by giving doctors a way to increase bone mass, not just slow its loss. ... > read full article
Tuesday, November 18, 2008
Bone Loss Problematic, Bone Drugs Risky
Numerous problems are associated with these drugs, including bone frailty and increased fracture rates.
Now chemotherapy for cancer seems to be opening a new window to ply these drugs on patients who already are health compromised because of the cancer and chemotherapy drug treatments.
It is interesting to note that there does exist a safe and effective approach to maintaining storng, healthy and flexible bones with vitamins and other natural supplements.
Some other physicians express concern -"
Bisphosphonates, like Fosamax and Actonel, are taken up by osteoclasts with resulting loss of osteoclast activity and inhibition of bone resorption, and bone remodeling (link). Although DEXA scanning confirms increased bone density and studies such as the FIT suggest reduced fracture rate, Susan Ott, MD raises questions about the long term safety of bisphosphonates. Although the bisphosphonates appear to have short term benefits, she speculates that after 5 years of use, there is severe suppression of bone formation with negative effects such as microdamage and brittleness.
Jennifer P. Schneider, MD, PhD reports a 59-year old previously healthy woman on long-term alendronate. While on a subway train in New York City one morning, the train jolted, and the woman shifted all her weight to one leg, felt a bone snap, and fell to the floor, suffering a spontaneous mid -femur fracture (see image). In the months following, it became clear that the fracture was not uniting. Schneider speculates that increased bone density from the bisphosphonate drug does not necessarily equate with good bone quality. By decreasing osteoclast activity and bone resorption, and therefore bone formation as well, microdamage, and brittle bone may result in fractures.
Odvina reports on 9 cases of spontanous fracture while on alendonate. Five of the nine cases were spontaneous mid femur fractures. Two had bilateral mid femur fractures same as Toulouse Lautrec. Six cases had delayed or absent fracture healing. Histomorphometric analysis of the cancellous bone showed markedly suppressed bone formation, and Odvina raised the possibility that severe suppression of bone turnover could develop during long-term alendronate therapy, resulting in increased susceptibility to, and delayed healing of, nonspinal fractures.
Dimitrakopoulos reports on 11 patients presenting with necrosis of the jaw, claiming this to be a new complication of bisphosphonate therapy administration, i.e. osteonecrosis of jaws. He advised clinicians to reconsider the merits of the rampant use of bisphosphonates. Osteonecrosis of the jaw is a common finding in pycnodysostosis. The bisphosphonates recreate the same clinical p rofile of spontaneous mid femur fractures, failure of bone healing and jaw necrosis which tormented Toulouse Lautrec.
In spite of this well known information, there are four more drugs in clinical trials which are specifically designed to inhibit cathepsin K, the enzyme defect in Lautrec's genetic bone disease. FDA approval for use in osteoporosis treatment is expected. Excuse me here, but perhaps this thinking needs re-evaluation. In essence we are creating a population of women with Toulouse Lautrec's bone disease. Ironically, women who sustain fractures while on Fosamax are told by their docs that the fractures are due to the underlying osteoporosis, not the drug. "
Cancer Treatment May Result In Bone Loss, Study Finds
ScienceDaily (2008-11-17) -- A new cross-Canada study has found that breast and prostate cancer treatment can foster bone loss. Scientists explain how loss of bone mass might affect 46,000 people diagnosed with breast and prostate cancer each year and place them at increased risk for osteoporosis and fractures. ... > read full article
FDA Issues Alert on Bone Drugs
By Elizabeth Trotta
The FDA posted an alert on Monday regarding possible severe, sometimes incapacitating bone, joint, and/or muscle pain in patients taking a class of bone-density drugs called bisphosphonates.
The possibility of such pain is listed in the drugs' prescribing information, but the FDA warned that doctors may overlook it to the point that it's prolonged or results in impairment, possibly requiring analgesics. This pain can occur days, months or years after initial use, and the risk factors for and incidence of severe musculoskeletal pain associated with the class are still unknown, according to the agency.
"Healthcare professionals should consider whether bisphosphonate use might be responsible for severe musculoskeletal pain in patients who present with these symptoms and consider temporary or permanent discontinuation of the drug," noted the health regulator in a Med Watch post on Monday.
The class of bone drugs in question include:
Proctor & Gamble's(PG Quote - Cramer on PG - Stock Picks) Actonel, Actonel +Ca, and Didronel
Novartis'(NVS Quote - Cramer on NVS - Stock Picks) Aredia, Reclast and Zometa
Roche and GlaxoSmithKline's(GSK Quote - Cramer on GSK - Stock Picks) Boniva
Merck's(MRK Quote - Cramer on MRK - Stock Picks) Foxamax, Fosamax + D
Sanofi Aventis'(SNY Quote - Cramer on SNY - Stock Picks) Skelid.
Drug companies downplay risks of bone-strengthening drugs for women
18.01.2008 Source: URL: http://english.pravda.ru/science/103518-bone_strengthening_drugs -0
Drug companies exaggerate the benefits and downplay the risks of prescribing bone-strengthening drugs for women whose bones are weakened but who do not have osteoporosis, a new report claims.
Drugs such as alendronate and risedronate do reduce the risk of fractures of women with osteoporosis, according to the article in the Jan. 19 issue of BMJ.
Alendronate is a bisphosphonate drug used for osteoporosis and several other bone diseases. It is marketed alone as well as in combination with vitamin D (2,800 U and 5600 U, under the name Fosamax+D). Merck's U.S. patent on alendronate is set to expire in 2008 and Merck has lost a series of appeals to block a generic version of the drug from being certified by the U.S. Food and Drug Administration.
Risedronate sodium is a bisphosphonate used to strengthen bone, treat or prevent osteoporosis, and treat Paget's disease of bone. It is produced and marketed by Procter & Gamble and Sanofi-Aventis.
In January 2006 P&G and its marketing partner Sanofi-Aventis filed a Lanham Act false claims lawsuit against rival drugmakers Roche and GlaxoSmithKline claiming false advertising about Boniva. The manufacturers of Boniva, a rival bisphosphonate, were accused in the suit of causing a "serious public health risk" through misrepresentation of scientific findings. In a ruling on on September 7 2006 U.S. District Judge Paul A. Crotty rejected P&G's attempted injunction. P&G was criticized for attempting to "preserve its market share by denigrating Boniva". Judge Crotty wrote that "Roche was clearly entitled to respond with its own data, provided that the data was truthfully and accurately presented".
Source: «PRAVDA.Ru».